PolyTherics Acquires Warwick Effect Polymers and Expands Technology Portfolio to Enable the Development of Better Biopharmaceuticals  
1/20/2012 6:42:19 AM

LONDON--(BUSINESS WIRE)--PolyTherics Limited (“PolyTherics”), a provider of solutions to biopharmaceutical companies for the improvement of protein and peptide based drugs, is pleased to announce the acquisition of Warwick Effect Polymers (“WEP”), a provider of specialty biopolymers for the modification of biological products.